Investigation of the association between Toll-like receptor 2 gene polymorphisms and Behçet's disease in Japanese patients

Human Immunology

Volumn 70, Issue 1, 2009, Pages 41-44

  Tomiyama, Ryuichi ^a   Meguro, Akira ^a   Ota, Masao ^b   Katsuyama, Yoshihiko ^b   Nishide, Tadayuki ^a   Uemoto, Riyo ^a   Iijima, Yasuhito ^a   Ohno, Shigeaki ^c   Inoko, Hidetoshi ^d   Mizuki, Nobuhisa ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Beh et's disease; Polymorphism; TLR2

Indexed keywords

TOLL LIKE RECEPTOR 2;

ARTICLE; BEHCET DISEASE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; BEHCET SYNDROME; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 2;

EID: 58149464687     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.10.014     Document Type: Article

References (45)

1. Kaklamani V.G., Vaiopoulos G., and Kaklamanis P.G. Behçet's disease. Semin Arthritis Rheum 27 (1998) 197-217
2. Ohno S., Ohguchi M., Hirose S., Matsuda H., Wakisaka A., and Aizawa M. Close association of HLA-Bw51 with Behçet's disease. Arch Opthalmol 100 (1982) 1455-1458
3. Yabuki K., Mizuki N., Ota M., Katsuyama Y., Palimeris G., Stavropoulos C., et al. Association of MICA gene and HLA-B*5101 with Behçet's disease in Greece. Invest Ophthalmol Vis Sci 40 (1999) 1921-1926
4. Mizuki N., Yabuki K., Ota M., Katsuyama Y., Ando H., Nomura E., et al. Analysis of microsatellite polymorphism around the HLA-B locus in Iranian patients with Behçet's disease. Tissue Antigens 60 (2002) 396-399
5. Mizuki N., Ohno S., Ando H., Chen L., Sato T., Imanishi T., et al. Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behçet's disease. Arthritis Rheum 42 (1999) 1961-1966
6. Sakane T. New perspective on Behçet's disease. Int Rev Immunol 14 (1997) 89-96
7. Carletto A., Pacor M.L., Biasi D., Caramaschi P., Zeminian S., Bellavite P., et al. Changes of neutrophil migration without modification of in vitro metabolism and adhesion in Behçet's disease. J Rheumatol 24 (1997) 1332-1336
8. Yoshida T., Tanaka M., Sotomatsu A., Okamoto K., and Hirai S. Serum of Behçet's disease enhances superoxide production of normal neutrophils. Free Radic Res 28 (1998) 39-44
9. Sahin S., Akoglu T., Direskeneli H., Sen L.S., and Lawrence R. Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behçet's disease. Ann Rheum Dis 55 (1996) 128-133
10. Lehner T., Lavery E., Smith R., van der Zee R., Mizushima Y., and Shinnick T. Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behçet's syndrome. Infect Immun 59 (1991) 1434-1441
11. Pervin K., Childerstone A., Shinnick T., Mizushima Y., van der Zee R., Hasan A., et al. T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease. J Immunol 151 (1993) 2273-2282
12. Direskeneli H., Hasan A., Shinnick T., Mizushima R., van der Zee R., Fortune F., et al. Recognition of B-cell epitopes of the 65 kDa HSP in Behçet's disease. Scand J Immunol 43 (1996) 464-471
13. Kaneko S., Suzuki N., Yamashita N., Nagafuchi H., Nakajima T., Wakisaka S., et al. Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behçet's disease (BD) in Japan. Clin Exp Immunol 108 (1997) 204-212
14. Mege J.L., Dilsen N., Sanguedolce V., Gul A., Bongrand P., Roux H., et al. Overproduction of monocyte derived tumor necrosis factor α, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheum 20 (1993) 1544-1549
15. Akira S., Takeda K., and Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2 (2001) 675-680
16. Andreakos E., Foxwell B., and Feldmann M. Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation?. Immunol Rev 202 (2004) 250-265
17. Kang S.S.W., Kauls L.S., and Gaspari A.A. Toll-like receptors: applications to dermatologic disease. J Am Acad Dermatol 54 (2006) 951-983
18. Meguro A., Ota M., Katsuyama Y., Oka A., Ohno S., Inoko H., et al. Association of the Toll-like receptor 4 gene polymorphisms with Behçet's disease. Ann Rheum Dis 67 (2008) 725-727
19. Bacanli A., Sallakci N., Yavuzer U., Alpsoy E., and Yegin O. Toll-like receptor 2 Arg753Gln gene polymorphism in Turkish patients with Behçet's disease. Clin Exp Dermatol 31 (2006) 699-701
20. Mizushima Y. Recent research into Behçet's disease in Japan. Int J Tissue React 10 (1998) 59-65
21. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
22. Gabriel S.B., Schaffner S.F., Nguyen H., et al. The structure of haplotype blocks in the human genome. Science 296 (2002) 2225-2229
23. Qin Z., Niu T., and Liu J. Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms. Am J Hum Genet 71 (2002) 1242-1247
24. Lorenz E., Mira J.P., Cornish K.L., Arbour N.C., and Schwartz D.A. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 68 (2000) 6398-6401
25. Kang T.J., and Chae G.T. Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol Med Microbiol 31 (2001) 53-58
26. Park Y., Park S., Yoo E., Kim D., and Shin H. Association of the polymorphism for Toll-like receptor 2 with type 1 diabetes susceptibility. Ann N Y Acad Sci 1037 (2004) 170-174
27. Boraska Jelavić T., Barisić M., Drmic Hofman I., Boraska V., Vrdoljak E., Peruzović M., et al. Microsatelite GT polymorphism in the Toll-like receptor 2 is associated with colorectal cancer. Clin Genet 70 (2006) 156-160
28. Tabel Y., Berdeli A., and Mir S. Association of TLR2 gene Arg753Gln polymorphism with urinary tract infection in children. Int J Immunogenet 34 (2007) 399-405
29. Ergun T., Ince U., Eksioglu-Demiralp E., Direskeneli H., Gurbuz O., Gurses L., et al. HSP 60 expression in mucocutaneous lesions of Behçet's disease. J Am Acad Dermatol 45 (2001) 904-909
30. Direskeneli H., Eksioglu-Demiralp E., Yavuz S., Ergun T., Shinnick T., Lehner T., et al. T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behçet's disease. J Rheumatol 27 (2000) 708-713
31. Kibaroglu A., Eksioglu-Demiralp E., Akoglu T., and Direskeneli H. T and NK cell subset changes with microbial extracts and human HSP60-derived peptides in Behçet's disease. Clin Exp Rheumatol 22 (2004) 59-63
32. Shaker O., El-Deen M.A.A., Hadidi H.E., Grace B.D., Sherif H.E., and Halim A.A. The role of heat shock protein 60, vascular endothelial growth factor and antiphospholipid antibodies in Behçet's disease. Br J Dermatol 156 (2007) 32-37
33. Lehner T. The role of heat shock protein, microbial and auto-immune agents in the aetiology of Behçet's disease. Int Rev Immunol 14 (1997) 21-32
34. Rietschel E.T., and Brade H. Bacterial endotoxins. Sci Am 267 (1992) 54-61
35. Hatemi G., Bahar H., Uysal S., Mat C., Gogus F., Masatlioglu S., et al. The pustular skin lesions in Behçet's syndrome are not sterile. Ann Rheum Dis 63 (2004) 1450-1452
36. Kirino Y., Takeno M., Watanabe R., Murakami S., Kobayashi M., Ideguchi H., et al. Association of reduced heme oxygenase-1 with excessive Toll-like receptor 4 expression in peripheral blood mononuclear cells in Behçet's disease. Arthritis Res Ther 10 (2008) R16
37. Sayinalp N., Ozcebe O.I., Ozdemir O., Haznedaroǧlu I.C., Dündar S., and Kirazli S. Cytokines in Behçet's disease. J Rheumatol 23 (1996) 321-322
38. Direskeneli H. Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 60 (2001) 996-1002
39. Hamzaoui K., Hamzaoui A., Guemira F., Bessioud M., Hamza M., and Ayed K. Cytokine profile in Behçet's disease patients. Relationship with disease activity. Scand J Rheumatol 31 (2002) 205-210
40. Alayli G., Aydin F., Coban A.Y., Süllü Y., Cantürk F., Bek Y., et al. T helper 1 type cytokines polymorphisms: association with susceptibility to Behçet's disease. Clin Rheumatol 26 (2007) 1299-1305
41. Hamzaoui K., Hamzaoui A., Kahan A., Hamza M., Chabbou A., and Ayed K. Interleukin-6 in peripheral blood and inflammatory sites in Behçet's disease. Mediators Inflamm 1 (1992) 281-285
42. Raziuddin S., al-Dalaan A., Bahabri S., Siraj A.K., and al-Sedairy S. Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern. J Rheumatol 25 (1998) 329-333
43. Aridogan B.C., Yildirim M., Baysal V., Inaloz H.S., Baz K., and Kaya S. Serum Levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Behçet's disease. J Dermatol 30 (2003) 602-607
44. Nara K., Kurokawa M.S., Chiba S., Yoshikawa H., Tsukikawa S., Matsuda T., et al. Involvement of innate immunity in the pathogenesis of intestinal Behçet's disease. Clin Exp Immunol 152 (2008) 245-251
45. Do J.E., Kwon S.Y., Park S., and Lee E.S. Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behçet's disease. Rheumatology 47 (2008) 840-848